Boston Therapeutics Inc Stock Price - BTHE

Best deals to access real time data!
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Boston Therapeutics (QB) BTHE OTC BB Common Stock Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.0002 -1% 0.0198 0.02 0.0102 0.02 0.02 16:30:16
Bid Price Ask Price Spread Spread % News
0.01 0.0198 0.0098 49.49% - -
Stock Trades Traded Volume Average Volume 52 Week Range
10 288,000 30.67k 0.01 - 0.12
Last Trade Time Type Quantity Stock Price Currency
15:22:25 200,000 $0.02 USD

Boston Therapeutics (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 2.18M 110.13M $ -4.6M - -0.47 26.05M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Boston Therapeutics (QB) News

Date Time Source News Article
12/06/201817:05Edgar (US Regulatory)Current Report Filing (8-k)
11/14/201811:09Edgar (US Regulatory)Quarterly Report (10-q)
8/14/201817:08Edgar (US Regulatory)Quarterly Report (10-q)
7/20/201813:00InvestorsHub NewsWireLevel Brands, Inc. Signs Deal with Boston Therapeutics
7/02/201815:53Edgar (US Regulatory)Current Report Filing (8-k)
6/14/201813:08Edgar (US Regulatory)Current Report Filing (8-k)
6/01/201812:06Edgar (US Regulatory)Current Report Filing (8-k)

Latest BTHE Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BTHE Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.030.030.01020.018510k136k77k-0.0102-34.00%
1 Month0.0340.03790.01020.0235730136k45k-0.0142-41.76%
3 Months0.03690.050.01020.0304500136k38k-0.0171-46.34%
6 Months0.06010.07490.01020.039960339k36k-0.0403-67.05%
1 Year0.06190.11640.01020.059760339k44k-0.0421-68.01%
3 Years0.110.170.01020.06563631k35k-0.0902-82.00%
5 Years1.321.320.01020.17193983k37k-1.3002-98.50%

Boston Therapeutics (QB) Description

Boston Therapeutics, Inc. (OTCQB: BTHE), headquartered in Lawrence, MA, is a leader in the field of designing drugs using complex carbohydrates. The Company's product pipeline is focused on developing and commercializing therapeutic molecules for diabetes, including: BTI-320, a non-systemic chewable compound designed to reduce post-meal glucose elevation; IPOXYN, an injectable anti-necrosis drug specifically designed to treat lower limb ischemia; and SUGARDOWN(R), an OTC dietary supplement designed to lower post-meal sugar spike. More information on BTHE is available at
Your Recent History
Boston The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190117 10:37:07